|
BioMimetic Therapeutics
cd98 crispr/cas9 ![]() Cd98 Crispr/Cas9, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd98 crispr/cas9/product/BioMimetic Therapeutics Average 90 stars, based on 1 article reviews
cd98 crispr/cas9 - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
BlueGene Biotech
cysteine aspartate-specific protease-9 ( cas-9 ) ![]() Cysteine Aspartate Specific Protease 9 ( Cas 9 ), supplied by BlueGene Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cysteine aspartate-specific protease-9 ( cas-9 )/product/BlueGene Biotech Average 90 stars, based on 1 article reviews
cysteine aspartate-specific protease-9 ( cas-9 ) - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Materials Today Bio
Article Title: Cell-derived biomimetic drug delivery system for inflammatory bowel disease therapy
doi: 10.1016/j.mtbio.2024.101332
Figure Lengend Snippet: Applications of BNDS based on cell membrane in IBD.
Article Snippet: MOF , C-dots and
Techniques: Membrane, Isolation, Inhibition, In Vitro, In Vivo, Mouse Assay, Capsules, CRISPR, Plasmid Preparation, Activity Assay, Expressing, Liposomes, Injection, Over Expression, Probiotics
Journal: Veterinary Medicine International
Article Title: Articular Cartilage Gene Expression after Coxofemoral Joint Luxation in the Dog
doi: 10.1155/2013/936317
Figure Lengend Snippet: The relationship between relative expression of apoptotic genes and days of luxation ( BAX , Bcl-2-associated X protein; BCL-2 , B-cell lymphoma-2; CAS-3 cysteine aspartate-specific protease-3; CAS-9 , cysteine aspartate-specific protease-9).
Article Snippet: Quantification of ten transcripts—aggrecan ( AGG ); type II collagen, alpha-1 chain ( COL2A1 ); matrix metalloproteinase-3 ( MMP-3 ); hyaluronan synthase-1 ( HAS-1 ); hyaluronan synthase-2 ( HAS-2 ); tissue inhibitor of metalloproteinase-1 ( TIMP-1 ); Bcl-2-associated X protein ( BAX ); B-cell lymphoma-2 ( BCL-2 ); cysteine aspartate-specific protease-3 ( CAS-3 ); and
Techniques: Expressing